Empowered Funds’s Avanos Medical AVNS Stock Holding History

Empowered Funds’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.45M	Sell	175,069 -39,293	-18%	-$529K	0.02%	994
2025 Q4	$2.41M	Buy	214,362 +20,807	+11%	+$238K	0.04%	434
2025 Q3	$2.24M	Buy	193,555 +22,367	+13%	+$262K	0.02%	863
2025 Q2	$2.1M	Buy	171,188 +9,006	+6%	+$113K	0.02%	799
2025 Q1	$2.32M	Buy	162,182 +8,348	+5%	+$130K	0.03%	679
2024 Q4	$2.45M	Buy	153,834 +90,091	+141%	+$1.78M	0.04%	644
2024 Q3	$1.53M	Sell	63,743 -127,491	-67%	-$2.91M	0.02%	766
2024 Q2	$3.81M	Buy	191,234 +13,680	+8%	+$266K	0.07%	401
2024 Q1	$3.54M	Buy	177,554 +13,409	+8%	+$259K	0.06%	418
2023 Q4	$3.68M	Buy	164,145 +14,784	+10%	+$305K	0.09%	310
2023 Q3	$3.02M	Buy	149,361 +12,166	+9%	+$276K	0.09%	307
2023 Q2	$3.51M	Buy	+137,195	New	+$3.61M	0.12%	210

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Empowered Funds's AVNS Position: Q1 2026 in Review

Empowered Funds reduced its Avanos Medical (AVNS) stake by 18% in Q1 2026, selling an estimated $529K and leaving 175,069 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #994.

Empowered Funds first reported a position in AVNS in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.81M in Q2 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Empowered Funds held 175,069 shares of Avanos Medical worth $2.45M as of Q1 2026.
Empowered Funds sold 39,293 Avanos Medical shares in Q1 2026, an estimated $529K.
Avanos Medical made up 0.02% of Empowered Funds's portfolio in Q1 2026, its #994 holding.
Empowered Funds first reported a position in Avanos Medical in Q2 2023 and has held it in 12 quarters since.
Empowered Funds's Avanos Medical position peaked at $3.81M in Q2 2024.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.